December 14, 2017 / 3:26 PM / 10 months ago

BRIEF-Medicure Acquires License To Sell Cardiovascular Drug In The U.S.

Dec 14 (Reuters) - Medicure Inc:

* MEDICURE ACQUIRES EXCLUSIVE LICENSE TO SELL AND MARKET BRANDED CARDIOVASCULAR DRUG IN THE U.S.

* MEDICURE INC - LICENSING AGREEMENT IS FOR A TERM OF SEVEN YEARS WITH EXTENSIONS TO TERM AVAILABLE

* MEDICURE - THROUGH ITS SUBSIDIARY CO HAS ACQUIRED LICENSE TO SELL AND MARKET A BRANDED CARDIOVASCULAR DRUG IN UNITED STATES AND ITS TERRITORIES

* MEDICURE - CO INTENDS TO LAUNCH THE PRODUCT WITH A TARGET COMMERCIAL LAUNCH DATE IN H1 OF 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below